Literature DB >> 14684295

Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.

Dawei Ma1, Wengen Wu, Guoxin Yang, Jingya Li, Jia Li, Qizhuang Ye.   

Abstract

The synthesis and MMP inhibitory activity of a series of tetrahydroisoquinoline based sulfonamide hydroxamates are described. In nine MMPs tested, most of the compounds display potent inhibition activity except for MMP-7. Some subtle isozyme selectivity is observed by varying the substituents at the 6- and 7-positions and aromatic ring of arylsulfonyl groups.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14684295     DOI: 10.1016/j.bmcl.2003.10.026

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

Review 1.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

2.  Synthesis and bioevaluation of [(18)F]4-fluoro-m-hydroxyphenethylguanidine ([(18)F]4F-MHPG): a novel radiotracer for quantitative PET studies of cardiac sympathetic innervation.

Authors:  Keun Sam Jang; Yong-Woon Jung; Phillip S Sherman; Carole A Quesada; Guie Gu; David M Raffel
Journal:  Bioorg Med Chem Lett       Date:  2013-01-30       Impact factor: 2.823

3.  Site-specific targeting of antibody activity in vivo mediated by disease-associated proteases.

Authors:  Oran Erster; Jerry M Thomas; Juliana Hamzah; Abeer M Jabaiah; Jennifer A Getz; Tobias D Schoep; Sejal S Hall; Erkki Ruoslahti; Patrick S Daugherty
Journal:  J Control Release       Date:  2012-05-23       Impact factor: 9.776

4.  Synthesis of novel (benzimidazolyl)isoquinolinols and evaluation as adenosine A1 receptor tools.

Authors:  Sameek Singh; Samantha L Cooper; Jacqueline R Glenn; Jessica Beresford; Lydia R Percival; Joel D A Tyndall; Stephen J Hill; Laura E Kilpatrick; Andrea J Vernall
Journal:  RSC Adv       Date:  2018-05-03       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.